Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 402 participants.

Also called NCT07370688

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 402 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07370688
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07370688. Randomized; no masking; primary purpose treatment. Start 2024-08-12 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation
Acronym
IRON TAVI
Condition
Aortic Valve Stenosis
Condition
Iron Deficiency
Condition
TAVI(Transcatheter Aortic Valve Implantation)
Condition
Cardiovascular Diseases
Intervention (Drug)
Intravenous ferric carboxymaltose
Lead sponsor
Erasmus Medical Center (class: other)

Record details

Record id
cardio:ct-nct07370688
Content hash
f284f669cd275c77e4af3d3d5585a8b4dc73692cb7c4133a34373f9d354a58e3